This was an observational study using Medicare data, and the limitations weren’t mentioned in the release.
More discussion on the study limitations and the test’s accuracy in ruling out the presence of disease (its specificity) would have made it even better.
The seemingly massive study size of the studies summarized here overshadow the minimal effects from hormone therapy.
The release goes beyond what the study leaders reported, even contradicting a study author quoted within the release.
What are the costs, harms, benefits, evidence, and novelty surrounding this estrogen treatment for vaginal dryness? The release doesn’t say.
News release on a new injectable biologic drug for psoriasis comes with strong cautions about side effects, but incomplete description of the evidence.
This release on an observational study of men taking testosterone therapy compared with those who did not fails to bring clarity to the testosterone replacement therapy research landscape.
Data on the benefits of the various rectal cancer treatments studied would have helped readers assess the significance of the research announcement.